Blog

Cardiotoxicity caused by cancer treatments, such as anthracyclines, is an increasingly recognized complication. Cancer and cardiovascular diseases share risk factors along with biological mechanisms, making it necessary the development of a collaborative approach between oncology, cardiology, and hematology. Before, during, and after treatment, active cardiovascular monitoring can detect potential heart

Cardiotoxicity is an alteration in the function of the heart muscle caused by certain cancer treatments, especially antineoplastic drugs such as anthracyclines. This dysfunction can progress to heart failure, one of the most serious complications in cancer patients. In the early stages, we speak of subclinical or preclinical cardiotoxicity, when

What is a clinical trial? Clinical trials are medical studies that allow us to find new, safe and effective ways to treat or prevent diseases. Before reaching this phase, treatments have been rigorously evaluated in the laboratory to ensure their viability. Only the most promising options advance to clinical trials.

Cancer is not the same in all people. Each tumor has unique characteristics and, therefore, treatments work differently for each patient. This is why biomarker tests can be of great help, as they guide doctors when choosing the most appropriate treatment for each person. What is biomarker testing and why

Christmas is here! And it is the time to celebrate, share and enjoy with our loved ones. However, on these dates we usually forget certain healthy regular habits such as exercising, eating in a balanced way, having a sleeping routine that helps us rest properly, etc., and then it comes

Cancer is one of the main causes of morbidity and mortality in Spain and in the world and it is highly recommended facing its treatment prepared on body and mind. One aspect that many people are unaware of is that some cancer treatments such as chemotherapy or radiotherapy can affect